Delivery Order SPE2DB22D1106-SPE2DB25FEZS9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors valued at $9,248.01, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract requires no set-aside designation, reflecting the competitive nature of the award. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector on July 21, 2025, with completion scheduled for August 11, 2025. This is a firm fixed price, non-set-aside contract utilizing competitively awarded pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Benlysta 200 mg/ml auto-injector units, valued at $18,496.02. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a $3,076.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/ml syringes, with an ultimate completion date of August 8, 2025. The contract, issued on July 18, 2025, carries no set-aside designation and represents a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,248.01 on July 21, 2025, for the supply of Benlysta 200 mg/ml auto-injectors under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The contract, which carries no set-aside designation, indicates competitively awarded procurement and is scheduled for completion by August 11, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200 mg/mL Benlysta autoinjectors. The $9,975.58 firm-fixed-price contract has a completion date of May 28, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and other government...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Benlysta 400 mg vials, with a ceiling value of $13,678.56 and firm fixed pricing. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 15, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/mL autoinjectors. The contract, valued at $5,779.12, has an ultimate completion date of January 14, 2025. This award is associated with AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,550.40 to AmerisourceBergen Drug Corp, a for-profit organization, to provide 120 mg vials of the pharmaceutical product BENLYSTA. The delivery order has a completion date of February 26, 2024 and was awarded on February 2, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as the prime contractor for this contract, which is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,793.03 firm fixed-price delivery order is for the supply of Benlysta 200 mg/mL autoinjector medication. The contract has an ultimate completion date of September 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZS9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $49,323 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 15, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications, medical devices, and healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, underscoring the strategic importance of pharmaceutical distribution to federal military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.3k | 7/25/25 |